Who Paid My Doc
Mark Schuyler
Allergy & Immunology Albuquerque, NM Medical Doctor
NPI 1144235607 CMS profile 537987
1 Unm, Msc10 5550, Albuquerque, NM 87131
General payments
$391
Research payments
$0
Ownership & investment interest
$0
Through program year 2023, Mark Schuyler of Albuquerque, NM is reported in the CMS Open Payments database as having received $391 across 5 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 20th percentile of Allergy & Immunology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
3 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2023 | General | $157 | 1 | |
| 2022 | General | $103 | 2 | |
| 2019 | General | $131 | 2 |
Beside peers
- Mark Schuyler
- Allergy & Immunology median
- Middle half of Allergy & Immunology
- National median
In program year 2025, general payments to Mark Schuyler were reported at $0. Among 2,466 Allergy & Immunology profiles paid that year, the median was $1,140 and the middle half received between $272 and $2,892.
Show as a table
| Year | Mark Schuyler | Allergy & Immunology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $131 | $594 | $163–$1,512 | $163 |
| 2020 | $0 | $426 | $106–$1,233 | $114 |
| 2021 | $0 | $638 | $157–$1,708 | $132 |
| 2022 | $103 | $790 | $205–$1,961 | $149 |
| 2023 | $157 | $852 | $220–$2,147 | $160 |
| 2024 | $0 | $865 | $203–$2,267 | $164 |
| 2025 | $0 | $1,140 | $272–$2,892 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 8 billing codesPaid by Medicare
$2,671
Medicare patients
20
Services billed
207
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 60% | |
| Heart failure | 0% | |
| Alzheimer's or dementia | 0% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
5 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Allergy & Immunology in New Mexico
Michael Rupp
Allergy & Immunology · Las Cruces, NM
Amanda Grippen Goddard
Allergy & Immunology · Albuquerque, NM
Jack Ghably
Allergy & Immunology · Albuquerque, NM
Shanze Wang
Allergy & Immunology · Albuquerque, NM
Osman Dokmeci
Allergy & Immunology · Albuquerque, NM
Corey Clay
Allergy & Immunology · Santa Fe, NM
Related records
Allergy & Immunology in New Mexico
Practitioners in the same specialty and state, ranked by reported value.
All Allergy & Immunology
Everyone recorded under this specialty, nationwide.
Doctors in New Mexico
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.